The vast majority of uterine leiomyomas (UL) either display clonal karyotype aberrations detected by classical cytogenetics or mutations of Mediator Subcomplex 12 (MED12) [1,2], or both. The gene discussed is MED12; the disease is uterine corpus leiomyoma.